Heparanase expression in both normal endometrium and endometrial cancer

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1401-1406

  Hasengaowa, ^a,b   Kodama, J ^a   Kusumoto, T ^a   Seki, N ^a   Matsuo, T ^a   Ojima, Y ^a   Nakamura, K ^a   Hongo, A ^a   Hiramatsu, Y ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Department of Obstetrics and Gynecology   (China)

Author keywords

Endometrial cancer; Endometrium; Heparanase; Prognosis

Indexed keywords

HEPARANASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CELL PROLIFERATION; CELL SECRETION; CONTROLLED STUDY; CYTOLOGY; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; GROWTH CURVE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MENSTRUAL CYCLE; MYOMETRIUM; OVERALL SURVIVAL; PERITONEUM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SPACE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GLUCURONIDASE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 33745111780     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00614.x     Document Type: Article

References (28)

1. Pikas DS Li JP Vlodavsky I Lindahl U. Substrate specificity of heparanase from human hepatoma and platelets. J Biol Chem 1998 273 : 18770 7.
2. Hulett MD Freeman C Hamdorf BJ Baker RT Harris MJ Parish CR. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 1999 5 : 803 9.
3. Toyoshima M Nakajima M. Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 1999 274 : 24153 60.
4. Vlodavsky I Friedmann Y Elkin M et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999 5 : 793 802.
5. Nakajima M Irimura T Di Ferrante N Nicolson G. Heparan sulfate degradation: relation to tumor invasion and metastatic properties of mouse B 16 melanoma sublines. Science 1983 220 : 611 3.
6. Vlodavsky I Fuks Z Bar-Ner M Ariav Y Schirrmacher V. Lymphoma cell mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res 1983 43 : 2704 11.
7. Vlodavsky I Korner G Ishai-Michaeli R Bashkin P Bar-Shavit R Fuks Z. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 1990 9 : 203 26.
8. Hasengaowa Kodama J Kusumoto T et al. Heparanase expression is a prognostic factor in patients with endometrial cancer. Oncol Rep. In press.
9. Parish CR Freeman C Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 2001 1471 : M99 108.
10. Keren Z Leland F Nakajima M LeGrue SJ. Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma. Cancer Res 1989 49 : 295 300.
11. Hasengaowa Kodama J Kusumoto T Shinyo Y Seki N Hiramatsu Y. Prognostic significance of syndecan-1 expression in human endometrial cancer. Ann Oncol 2005 16 : 1109 15.
12. Vlodavsky I Goldshmidt O Zcharia E et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 2002 12 : 121 9.
13. Ikuta M Podyma KA Maruyama K Enomoto S Yanagishita M. Expression of heparanase in oral cancer cell lines and oral cancer tissues. Oral Oncol 2001 37 : 177 84.
14. Mikami S Ohashi K Usui Y et al. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res 2001 92 : 1062 73.
15. Gohji K Hirano H Okamoto M et al. Expression of three extracellular matrix degradative enzymes in bladder cancer. Int J Cancer 2001 95 : 295 301.
16. Nobushita T Naomoto Y Ohkawa T et al. Heparanase expression correlates with malignant potential in human colon cancer. J Cancer Res Clin Oncol 2005 131 : 229 37.
17. Koliopanos A Friess H Kleff J et al. Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 2001 61 : 4655 65.
18. El-Assai ON Yamanoi A Ono T Kohno H Nagasue N. The clinicopathological significance of heparanase and basic fibroblast growth factor expression in hepatocellular carcinoma. Clin Cancer Res 2001 7 : 1299 305.
19. Tang W Nakamura Y Tsujimoto M et al. Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod Pathol 2002 15 : 593 8.
20. Shinyo Y Kodama J Hongo A Yoshinouchi M Hiramatsu Y. Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer. Ann Oncol 2003 14 : 1505 10.
21. Takahashi H Ebihara S Okazaki T et al. Clinical significance of heparanase activity in primary resected non-small cell lung cancer. Lung Cancer 2004 45 : 207 14.
22. Beckhove P Helmke BM Ziouta Y et al. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis. Clin Cancer Res 2005 11 : 2899 906.
23. Ueno Y Yamamoto M Vlodavsky I Pecker I Ohshima K Fukushima T. Decreased expression of heparanase in glioblastoma multiforme. J Neurosurg 2005 102 : 513 21.
24. Stadmann S Moser PL Pollheimer J et al. Heparanase-1 gene expression in normal, hyperplastic and neoplastic prostatic tissue. Eur J Cancer 2003 39 : 2229 33.
25. Kodama J Shinyo Y, Hasengaowa et al. Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer. Oncol Rep 2005 14 : 89 92.
26. Hasengaowa Kodama J Kusumoto T et al. Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer. Eur J Gynaecol Oncol 2005 26 : 403 6.
27. Watanabe M Aoki Y Kase H Tanaka K. Heparanase expression and angiogenesis in endometrial cancer. Gynecol Obstet Invest 2003 56 : 77 82.
28. Rohloff J Zinke J Schoppmeyer K et al. Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J cancer 2002 86 : 1270 5.